Tamoxifen as an effective treatment for refractory mania: a case report

Author:

Moya-Sánchez Deldhy Nicolas,Escamilla-Diaz Daniel,Gutierrez-Gonzalez José Antonio,Ochoa-Madrigal Marta Georgina,Meneses-Luna Oscar,Moya-Sánchez Alexia,Lugo-Gálvez Orlando,Cruz-Aviña Francisco Javier,Salazar-Rodríguez Alejandro,Nuñez-Pichardo Sharon Venecia,Chavez-Martinez Emmanuel Alejandro

Abstract

Tamoxifen is a medication that acts as a selective estrogen receptor modulator (SERM) by inhibiting protein kinase C (PKC). It has various effects on different tissues in the body, depending on whether the tissue expresses estrogen receptors. For instance, it can reduce inflammation and neuronal excitability. Several studies have shown that tamoxifen could be effective in treating refractory mania, a type of mania that has shown resistance to mood stabilizers and other treatments. The rationale for its use could be explained by the fact that PKC is an enzyme that seemingly plays a significant role in the genesis of mania. We present the case of a 43-year-old female patient with bipolar disorder, who has had 43 previous hospitalizations and has undergone multiple treatments. Management with tamoxifen was initiated to control the manic episode. 

Publisher

South Florida Publishing LLC

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3